Home > Financial Ratios > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 2.948.04-2.5010.697.21

What is the latest Core EBITDA Margin ratio of AKUMS DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of AKUMS DRUGS & PHARMACEUTICALS is 2.94 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar20242.94
Mar20238.04
Mar2022-2.50
Mar202110.69
Mar20207.21

How is Core EBITDA Margin of AKUMS DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2024 2.94
-63.43
Mar2023 8.04
Positive
Mar2022 -2.5
Negative
Mar2021 10.69
48.27
Mar2020 7.21 -

Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of AKUMS DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS ₹8,279.2 Cr 4% 12% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS

4%

12%

NA
SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses